Success stories: Bharat Biotech's contributions to Make in India

Bharat Biotech's indigenous vaccines, including COVAXIN®, have not only played a vital role in the country's fight against COVID-19 but have also been exported to several countries, demonstrating India's manufacturing prowess.

In addition to vaccines, Bharat Biotech has made significant contributions to the development of therapeutic products and biotech-based solutions for various infectious and neglected diseases. These achievements have not only improved healthcare outcomes but have also fostered job creation, skill development, and economic growth.

How Make in India and biotech will shape India's growth

Looking ahead, both, ‘Make in India' and the biotech industry will continue to shape India's growth trajectory. The government's continued support for innovation, research, and manufacturing in the biotech sector, coupled with the industry's commitment to excellence, will pave the way for transformative advancements.

Bharat Biotech, with its strong R&D pipeline, is actively pursuing the development of future vaccines for malaria, cholera, tuberculosis, and others, after delivering 9 billion doses of indigenous vaccines in over 125 countries over the last two decades. The company's expansion plans, international collaborations, and path-breaking research initiatives will further strengthen India's position as a global leader in biotechnology and manufacturing.

Reflecting on 10 years of Make in India and the role of Bharat Biotech

As we celebrate 10 years of the Make in India campaign, it is essential to recognise the immense contributions of vaccines, biotechnology, and collaborative efforts in shaping India's success story. Bharat Biotech's innovation, manufacturing excellence, and collaborations helped India become self-reliant and globally recognised.

As we look towards the future, it is evident that Make in India and the biotech industry will continue to drive India's growth, creating opportunities for economic development, job creation, and healthcare advancements. With a committed new investment of Rs 2,000 crores between 2019 and 2024 by Bharat Biotech, India's biotech sector is poised for even greater achievements, cementing its position as a global powerhouse in innovation and manufacturing.